Dietmar Berger

Companies

• Gilead SciencesChief Medical Officer Jan 3, 2025 to now¹
• Arcus BiosciencesBoard member Feb 10, 2025 to Feb 10, 2025²
• Atara Biotherapeutics, Inc.Global Head of R&D May 7, 2018 to May 8, 2019³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• GSGilead Sciences GILD19,522 shares⁴$3.0M at $153.68Sep 10, 2026
• ABArcus Biosciences RCUS0 shares⁵Feb 10, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 10, 2026Shares withheld for tax 263 shares at $144.81 of Gilead Sciences⁴
• Sep 10, 2026Exercised options 533 shares of Gilead Sciences⁴
• Jun 10, 2026Shares withheld for tax 263 shares at $121.48 of Gilead Sciences⁶
• Jun 10, 2026Exercised options 533 shares of Gilead Sciences⁶
• Mar 10, 2026Shares withheld for tax 1,063 shares at $148.56 of Gilead Sciences⁷
• Mar 10, 2026Exercised options 2,133 shares of Gilead Sciences⁷
• Feb 27, 2026Granted 8,530 shares of Gilead Sciences⁸
• Jan 2, 2026Shares withheld for tax 6,944 shares at $121.60 of Gilead Sciences⁹
• Jan 2, 2026Exercised options 16,326 shares of Gilead Sciences⁹